What to watch with Östradiol and longevity?

The relationship between estradiol and longevity is complex and not directly addressed in the provided context. Estradiol, the primary estrogen, has both protective and potentially harmful effects on health. In premenopause, it supports cardiovascular health and bone density, while postmenopausal decline is linked to increased risks of osteoporosis and cardiovascular disease. Long-term hormone replacement therapy (HRT) studies show mixed outcomes: benefits for bone and vasomotor symptoms, but possible increased risks for breast cancer and thromboembolic events. Genetic variants in estrogen receptor genes (ESR1, ESR2) or the aromatase gene (CYP19A1) may modestly influence estradiol metabolism, but effect sizes are small and insufficient for personalized longevity guidance. Evidence is primarily mechanistic and observational. For reliable assessment, regular hormone blood tests, lifestyle factors (diet, exercise, sleep), and medical supervision are essential. DNA tests alone do not provide a sufficient basis for HRT decisions.